Tips for 2011: Pharmaceuticals back in vogue and organic growth becomes key issue
TIPS FOR 2011
Jeremy Batstone-Carr
Jeremy Batstone-Carr, director of private client research at stockbroker Charles Stanley, reveals his picks for 2011
AstraZeneca A bold call for 2011 undoubtedly. Not only are pharmaceutical stocks likely to be more in vogue in 2012, but if equity markets blaze higher over 2011 the shares may lag. Operationally, investors...
More on Investment
Back to Top
